Dr. Enitan A Sogbesan, MD
Claim this profileStudies Ocular Hypertension
Studies Glaucoma
1 reported clinical trial
2 drugs studied
More about Enitan A Sogbesan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Enitan A Sogbesan, MD has experience with
- Fluorometholone
- Ketorolac
Breakdown of trials Enitan A Sogbesan, MD has run
Ocular Hypertension
Inflammatory Response
Open-Angle Glaucoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Enitan A Sogbesan, MD specialize in?
Enitan A Sogbesan, MD focuses on Ocular Hypertension and Glaucoma. In particular, much of their work with Ocular Hypertension has involved treating patients, or patients who are undergoing treatment.
Is Enitan A Sogbesan, MD currently recruiting for clinical trials?
No, Enitan A Sogbesan, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Enitan A Sogbesan, MD has studied deeply?
Yes, Enitan A Sogbesan, MD has studied treatments such as Fluorometholone, Ketorolac.
What is the best way to schedule an appointment with Enitan A Sogbesan, MD?
Apply for one of the trials that Enitan A Sogbesan, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.